Trevi Therapeutics (TRVI) Held by Superinvestors
TREVI THERAPEUTICS INC (TRVI) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $28.81M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Viking Global Investors is currently the largest disclosed institutional shareholder of TRVI tracked by InsiderSet, reporting ownership valued at approximately $28.81M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $19.48M, representing an estimated loss of -32.39% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed TRVI value among the investors covered in this analysis. Major shareholders include Viking Global Investors, and several other long-term asset managers with concentrated positions in TREVI THERAPEUTICS INC (TRVI).
This page ranks the largest institutional TRVI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Viking Global Investors | Ole Andreas Halvorsen | 0.08% | 1,544,644 | $28,807,611 | $19,477,961 | -$9,329,650 | -32.39% |
Frequently asked questions about TRVI
Who are the largest superinvestors holding TRVI?
The largest superinvestors holding TRVI in the latest SEC Form 13F filings include Viking Global Investors. InsiderSet ranks these superinvestors by their latest reported TRVI position.
What does the TRVI superinvestors page include?
This page tracks TRVI positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. TREVI THERAPEUTICS INC (TRVI) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold TRVI?
InsiderSet currently tracks 1 superinvestors reporting TRVI holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own TRVI.
How much TRVI stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $28.81M in TRVI holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were TRVI superinvestor holdings last updated?
The latest TRVI superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor TRVI holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its TRVI position after the reporting date.
Are superinvestors buying or selling TRVI?
Buying and selling can be analyzed by comparing TRVI positions across consecutive 13F reporting periods. InsiderSet's TRVI Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TRVI ownership changes.
How have superinvestor TRVI holdings changed over time?
InsiderSet tracks TRVI holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.